These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26454237)

  • 1. A novel 5HT3 antagonist 4i (N-(3-chloro-2-methylphenyl)quinoxalin-2-carboxamide) prevents diabetes-induced depressive phenotypes in mice: Modulation of serotonergic system.
    Gupta D; Thangaraj D; Radhakrishnan M
    Behav Brain Res; 2016 Jan; 297():41-50. PubMed ID: 26454237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models.
    Gupta D; Radhakrishnan M; Thangaraj D; Kurhe Y
    Eur J Pharmacol; 2014 Jul; 735():59-67. PubMed ID: 24747753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: possible implication of serotonergic system.
    Gupta D; Radhakrishnan M; Kurhe Y
    Eur J Pharmacol; 2014 Dec; 744():59-66. PubMed ID: 25284215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a novel 5-HT3 receptor antagonist 4i, in corticosterone-induced depression-like behavior and oxidative stress in mice.
    Gupta D; Radhakrishnan M; Kurhe Y
    Steroids; 2015 Apr; 96():95-102. PubMed ID: 25668613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5HT3 receptor antagonist (ondansetron) reverses depressive behavior evoked by chronic unpredictable stress in mice: modulation of hypothalamic-pituitary-adrenocortical and brain serotonergic system.
    Gupta D; Radhakrishnan M; Kurhe Y
    Pharmacol Biochem Behav; 2014 Sep; 124():129-36. PubMed ID: 24909071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression.
    Gupta D; Radhakrishnan M; Kurhe Y; Thangaraj D; Prabhakar V; Kanade P
    Acta Pharmacol Sin; 2014 Dec; 35(12):1493-503. PubMed ID: 25418380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5HT3 receptors: Target for new antidepressant drugs.
    Gupta D; Prabhakar V; Radhakrishnan M
    Neurosci Biobehav Rev; 2016 May; 64():311-25. PubMed ID: 26976353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice.
    Kurhe Y; Radhakrishnan M; Gupta D; Devadoss T
    J Pharm Pharmacol; 2014 Jan; 66(1):122-32. PubMed ID: 24180368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant effects of insulin in streptozotocin induced diabetic mice: Modulation of brain serotonin system.
    Gupta D; Kurhe Y; Radhakrishnan M
    Physiol Behav; 2014 Apr; 129():73-8. PubMed ID: 24582678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropharmacological effect of novel 5-HT3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) on chronic unpredictable mild stress-induced molecular and cellular response: Behavioural and biochemical evidences.
    Bhatt S; Mahesh R; Jindal A; Devadoss T
    Pharmacol Rep; 2014 Oct; 66(5):804-10. PubMed ID: 25149984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of (4a) a novel 5-HT3 receptor antagonist on chronic unpredictable mild stress induced depressive-like behavior in mice: an approach using behavioral tests battery.
    Kurhe Y; Mahesh R; Gupta D; Thangaraj D
    J Basic Clin Physiol Pharmacol; 2015 Jan; 26(1):25-33. PubMed ID: 24706431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-depressant-like activity of a novel serotonin type-3 (5-HT3) receptor antagonist in rodent models of depression.
    Gupta D; Devadoss T; Bhatt S; Gautam B; Jindal A; Pandey D; Mahesh R
    Indian J Exp Biol; 2011 Aug; 49(8):619-26. PubMed ID: 21870430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of a novel 5-HT3 receptor antagonist, N-n-butyl-3-methoxy quinoxaline-2-carboxamide (6o) against chronic unpredictable mild stress-induced behavioral changes and biochemical alterations.
    Bhatt S; Mahesh R; Jindal A; Devadoss T
    Pharmacol Biochem Behav; 2014 Jul; 122():234-9. PubMed ID: 24769308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QCM-4, a 5-HT₃ receptor antagonist ameliorates plasma HPA axis hyperactivity, leptin resistance and brain oxidative stress in depression and anxiety-like behavior in obese mice.
    Kurhe Y; Mahesh R; Devadoss T
    Biochem Biophys Res Commun; 2015 Jan; 456(1):74-9. PubMed ID: 25446100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropharmacological and neurochemical evaluation of N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n): a novel serotonergic 5-HT3 receptor antagonist for co-morbid antidepressant- and anxiolytic-like potential using traumatic brain injury model in rats.
    Bhatt S; Mahesh R; Jindal A; Devadoss T
    J Basic Clin Physiol Pharmacol; 2017 Mar; 28(2):93-100. PubMed ID: 27662644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antidepressant-like effect of 7-fluoro-1,3-diphenylisoquinoline-1-amine in the mouse forced swimming test is mediated by serotonergic and dopaminergic systems.
    Pesarico AP; Sampaio TB; Stangherlin EC; Mantovani AC; Zeni G; Nogueira CW
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():179-86. PubMed ID: 24936772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant & anxiolytic activities of N-(pyridin-3-yl) quinoxalin-2-carboxamide: A novel serotonin type 3 receptor antagonist in behavioural animal models.
    Pandey DK; Devadoss T; Modak N; Mahesh R
    Indian J Med Res; 2016 Oct; 144(4):614-621. PubMed ID: 28256473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropharmacological evaluation of a novel 5-HT3 receptor antagonist (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl) methanone (6g) on lipopolysaccharide-induced anxiety models in mice.
    Bhatt S; Mahesh R; Devadoss T; Jindal A
    J Basic Clin Physiol Pharmacol; 2017 Mar; 28(2):101-106. PubMed ID: 27664773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin 5-HT
    Perez-Palomar B; Mollinedo-Gajate I; Berrocoso E; Meana JJ; Ortega JE
    Neuropharmacology; 2018 May; 133():491-502. PubMed ID: 29477299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.
    Dukat M; Alix K; Worsham J; Khatri S; Schulte MK
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5945-8. PubMed ID: 24035337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.